In agreement with previous studies [45,46], our study also showed that VOdipic-Cl improves liver lipid metabolism disorders by down-regulating the expression of PPARγ, C/EBPa, SREBP-1c and FAS proteins related to lipid synthesis. This evidence concerns the gene SREBF1 and Disorder of lipid metabolism.